Literature DB >> 22217705

Lysophosphatidic acids are new substrates for the phosphatase domain of soluble epoxide hydrolase.

Ami Oguro1, Susumu Imaoka2.   

Abstract

Soluble epoxide hydrolase (sEH) is a bifunctional enzyme that has a C-terminus epoxide hydrolase domain and an N-terminus phosphatase domain. The endogenous substrates of epoxide hydrolase are known to be epoxyeicosatrienoic acids, but the endogenous substrates of the phosphatase activity are not well understood. In this study, to explore the substrates of sEH, we investigated the inhibition of the phosphatase activity of sEH toward 4-methylumbelliferyl phosphate by using lecithin and its hydrolyzed products. Although lecithin itself did not inhibit the phosphatase activity, the hydrolyzed lecithin significantly inhibited it, suggesting that lysophospholipid or fatty acid can inhibit it. Next, we investigated the inhibition of phosphatase activity by lysophosphatidyl choline, palmitoyl lysophosphatidic acid, monopalmitoyl glycerol, and palmitic acid. Palmitoyl lysophosphatidic acid and fatty acid efficiently inhibited phosphatase activity, suggesting that lysophosphatidic acids (LPAs) are substrates for the phosphatase activity of sEH. As expected, palmitoyl, stearoyl, oleoyl, and arachidonoyl LPAs were efficiently dephosphorylated by sEH (Km, 3-7 μM; Vmax, 150-193 nmol/min/mg). These results suggest that LPAs are substrates of sEH, which may regulate physiological functions of cells via their metabolism.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22217705      PMCID: PMC3276473          DOI: 10.1194/jlr.M022319

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  36 in total

1.  Effects of human soluble epoxide hydrolase polymorphisms on isoprenoid phosphate hydrolysis.

Authors:  Ahmed E Enayetallah; David F Grant
Journal:  Biochem Biophys Res Commun       Date:  2006-01-10       Impact factor: 3.575

2.  Cyclic phosphatidic acid is produced by autotaxin in blood.

Authors:  Satomi Tsuda; Shinichi Okudaira; Keiko Moriya-Ito; Chie Shimamoto; Masayuki Tanaka; Junken Aoki; Hiroyuki Arai; Kimiko Murakami-Murofushi; Tetsuyuki Kobayashi
Journal:  J Biol Chem       Date:  2006-07-12       Impact factor: 5.157

Review 3.  Action of epoxyeicosatrienoic acids on cellular function.

Authors:  Arthur A Spector; Andrew W Norris
Journal:  Am J Physiol Cell Physiol       Date:  2006-09-20       Impact factor: 4.249

4.  Three mammalian lipins act as phosphatidate phosphatases with distinct tissue expression patterns.

Authors:  Jimmy Donkor; Meltem Sariahmetoglu; Jay Dewald; David N Brindley; Karen Reue
Journal:  J Biol Chem       Date:  2006-12-07       Impact factor: 5.157

5.  Activation of hypoxia-inducible factor-1alpha is necessary for lysophosphatidic acid-induced vascular endothelial growth factor expression.

Authors:  Jangsoon Lee; Soon Young Park; Eun Kyung Lee; Chang Gyo Park; Hyun Cheol Chung; Sun Young Rha; Yong Kee Kim; Gyu-Un Bae; Bum Kyeong Kim; Jeung-Whan Han; Hoi Young Lee
Journal:  Clin Cancer Res       Date:  2006-11-01       Impact factor: 12.531

Review 6.  Epoxyeicosatrienoic acids, cell signaling and angiogenesis.

Authors:  Ingrid Fleming
Journal:  Prostaglandins Other Lipid Mediat       Date:  2006-07-11       Impact factor: 3.072

7.  The Saccharomyces cerevisiae PHM8 gene encodes a soluble magnesium-dependent lysophosphatidic acid phosphatase.

Authors:  Venky Sreedhar Reddy; Arjun Kumar Singh; Ram Rajasekharan
Journal:  J Biol Chem       Date:  2008-01-30       Impact factor: 5.157

Review 8.  Thematic Review Series: Glycerolipids. Multiple roles for lipins/phosphatidate phosphatase enzymes in lipid metabolism.

Authors:  Karen Reue; David N Brindley
Journal:  J Lipid Res       Date:  2008-09-12       Impact factor: 5.922

9.  Opposite regulation of cholesterol levels by the phosphatase and hydrolase domains of soluble epoxide hydrolase.

Authors:  Ahmed E EnayetAllah; Ayala Luria; Beibei Luo; Hsing-Ju Tsai; Priyanka Sura; Bruce D Hammock; David F Grant
Journal:  J Biol Chem       Date:  2008-10-29       Impact factor: 5.157

10.  Insights into the catalytic mechanism of human sEH phosphatase by site-directed mutagenesis and LC-MS/MS analysis.

Authors:  Annette Cronin; Shirli Homburg; Heike Dürk; Ingrid Richter; Magdalena Adamska; Frederic Frère; Michael Arand
Journal:  J Mol Biol       Date:  2008-08-27       Impact factor: 5.469

View more
  12 in total

1.  Soluble epoxide hydrolase as an anti-inflammatory target of the thrombolytic stroke drug SMTP-7.

Authors:  Naoki Matsumoto; Eriko Suzuki; Makoto Ishikawa; Takumi Shirafuji; Keiji Hasumi
Journal:  J Biol Chem       Date:  2014-10-31       Impact factor: 5.157

2.  Structure-activity relationships of the plasminogen modulator SMTP with respect to the inhibition of soluble epoxide hydrolase.

Authors:  Naoki Matsumoto; Eriko Suzuki; Kota Tsujihara; Yuuichi Nishimura; Keiji Hasumi
Journal:  J Antibiot (Tokyo)       Date:  2015-05-13       Impact factor: 2.649

Review 3.  Arachidonic acid monooxygenase: Genetic and biochemical approaches to physiological/pathophysiological relevance.

Authors:  Jorge H Capdevila; Wenhui Wang; John R Falck
Journal:  Prostaglandins Other Lipid Mediat       Date:  2015-05-15       Impact factor: 3.072

4.  Discovery of the First in Vivo Active Inhibitors of the Soluble Epoxide Hydrolase Phosphatase Domain.

Authors:  Jan S Kramer; Stefano Woltersdorf; Thomas Duflot; Kerstin Hiesinger; Felix F Lillich; Felix Knöll; Sandra K Wittmann; Franca-M Klingler; Steffen Brunst; Apirat Chaikuad; Christophe Morisseau; Bruce D Hammock; Carola Buccellati; Angelo Sala; G Enrico Rovati; Matthieu Leuillier; Sylvain Fraineau; Julie Rondeaux; Victor Hernandez-Olmos; Jan Heering; Daniel Merk; Denys Pogoryelov; Dieter Steinhilber; Stefan Knapp; Jeremy Bellien; Ewgenij Proschak
Journal:  J Med Chem       Date:  2019-09-17       Impact factor: 7.446

Review 5.  Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases.

Authors:  Karen M Wagner; Cindy B McReynolds; William K Schmidt; Bruce D Hammock
Journal:  Pharmacol Ther       Date:  2017-06-19       Impact factor: 12.310

Review 6.  Redox Regulation of Soluble Epoxide Hydrolase-Implications for Cardiovascular Health and Disease.

Authors:  Rebecca Charles; Philip Eaton
Journal:  Cells       Date:  2022-06-15       Impact factor: 7.666

Review 7.  Cytochrome P450 epoxygenase pathway of polyunsaturated fatty acid metabolism.

Authors:  Arthur A Spector; Hee-Yong Kim
Journal:  Biochim Biophys Acta       Date:  2014-08-02

Review 8.  The 2014 Bernard B. Brodie award lecture-epoxide hydrolases: drug metabolism to therapeutics for chronic pain.

Authors:  Sean D Kodani; Bruce D Hammock
Journal:  Drug Metab Dispos       Date:  2015-03-11       Impact factor: 3.922

Review 9.  Crossing signals: bioactive lipids in the microvasculature.

Authors:  Dawid S Chabowski; Katie E Cohen; Ossama Abu-Hatoum; David D Gutterman; Julie K Freed
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-04-03       Impact factor: 5.125

10.  Role of phosphatase activity of soluble epoxide hydrolase in regulating simvastatin-activated endothelial nitric oxide synthase.

Authors:  Hsin-Han Hou; Yi-Jen Liao; Sheng-Huang Hsiao; Song-Kun Shyue; Tzong-Shyuan Lee
Journal:  Sci Rep       Date:  2015-08-25       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.